Home › Ulcerative Colitis › Texas › San Antonio
Ulcerative Colitis clinical trials in San Antonio, TX
16 studies for Ulcerative Colitis are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RecruitingPhase 2
- Southern Star Research Institute /ID# 280822, San Antonio
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RecruitingPhase 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RecruitingPhase 2
- Southern Star Research Institute, San Antonio
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
RecruitingPhase 2
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
RecruitingPhase 4
- Gastroenterology Research of San Antonio, LLC, San Antonio
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
RecruitingPhase 1/2Healthy volunteers welcome
- Xencor Investigative Site, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RecruitingPhase 3
- Southern Star Research Institute ( Site 0299), San Antonio
Confirmatory Clinical Study in Active Ulcerative Colitis
RecruitingPhase 2
- Southern Star Research Institute, San Antonio
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- Southern Star Research Institute, LLC, San Antonio
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RecruitingPhase 2
- Site 002, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Gastroenterology Research of San Antonio, San Antonio
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
RecruitingObservational study
- Brooke Army Medical center, San Antonio
- Brooke Army Medical center, San Antonio
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- New York City, NY24 studies
- Miami, FL22 studies
- Orlando, FL22 studies
- Houston, TX17 studies
- San Diego, CA15 studies
- Chicago, IL15 studies
- Tacoma, WA14 studies
- Colorado Springs, CO14 studies
- Tyler, TX13 studies
- Los Angeles, CA13 studies
- St. Louis, MO13 studies
- Washington, DC12 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer59 studies
- Breast Cancer46 studies
- Colorectal Cancer46 studies
- Metastatic Cancer44 studies
- Cancer (all types)41 studies
- Obesity40 studies
- Type 2 Diabetes36 studies
- Overweight34 studies
- Pancreatic Cancer31 studies
- Ovarian Cancer31 studies
- Prostate Cancer28 studies
- Endometrial Cancer27 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.